awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34515513-0C5FDE4E-C84D-43AF-A809-31BC2A5CB482
Q34515513-0C5FDE4E-C84D-43AF-A809-31BC2A5CB482
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34515513-0C5FDE4E-C84D-43AF-A809-31BC2A5CB482
COX-2 inhibitors compared and contrasted.
P2860
Q34515513-0C5FDE4E-C84D-43AF-A809-31BC2A5CB482
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34515513-0C5FDE4E-C84D-43AF-A809-31BC2A5CB482
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a44d6b9b9995c51528800ebb9387eab88add16a
P2860
Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthriti